Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.665
+0.110 (3.09%)
Nov 6, 2026, 2:26 PM EST - Market open
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $377.48 million as of November 6, 2026. It is the 16,481st most valuable company in the world and the 2,946th biggest in the United States. Its market cap has increased by 256.70% in one year.
Market Cap
377.48M
Enterprise Value
243.37M
1-Year Change
256.70%
Global Rank
Country Rank
#2,946 United States
Category
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $377.48M, a decrease of -53.20%. That is a compound annual growth rate of -11.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 377.48M | 57.97% |
| Dec 31, 2025 | 238.95M | 147.03% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Assembly Biosciences | 405.58M |
| Editas Medicine | 399.31M |
| Altimmune | 396.82M |
| C4 Therapeutics | 394.91M |
| BlossomHill Therapeutics | 394.45M |
| Avalo Therapeutics | 388.82M |
| Allogene Therapeutics | 386.95M |
| Zura Bio | 384.34M |